Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693133 · ClinicalTrials.gov registry record · NA
Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT01693133 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 132 participants.
The verdict
NCT01693133, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the percentage of patients with complete diabetic foot ulcer (DFU) closure following up to 12 weeks of treatment with either dehydrated human amnion/chorion membrane (dHACM) plus standard of care (SOC) or SOC alone.
Interventions
- OTHER Standard of Care: Moist Wound Therapy and Offloading
- OTHER EpiFix plus Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2012-07 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693133
The ClinicalTrials.gov registry entry for NCT01693133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care: Moist Wound Therapy and Offloading is the first listed.
NCT01693133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01693133 about?
NCT01693133 is a clinical study titled "Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers". The objective of this study is to evaluate the percentage of patients with complete diabetic foot ulcer (DFU) closure following up to 12 weeks of treatment with either dehydrated human amnion/chorion membrane (dHACM) plus standard of care (SOC) or SOC alone.
What is the current status of trial NCT01693133?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2012-07. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01693133?
The interventions under investigation include: Standard of Care: Moist Wound Therapy and Offloading (OTHER), EpiFix plus Standard of Care (OTHER).
Who is sponsoring clinical trial NCT01693133?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.